Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$64,730,841
+$17,323,137 QoQ
Shares Held
53,968
+4.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#480
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $211,410,302 across 13 Drug Manufacturers - General names. LLY ranks #1 (30.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
53,968 | $64,730,841 | |
| 2 | JNJ |
Johnson & Johnson
|
138,783 | $35,246,716 | |
| 3 | ABBV |
AbbVie Inc.
|
126,735 | $31,891,592 | |
| 4 | AZN |
Astrazeneca PLC
|
85,578 | $16,227,298 | |
| 5 | MRK |
Merck & Co., Inc.
|
111,985 | $14,390,071 | |
| 6 | NVS |
Novartis AG
|
81,258 | $12,734,752 | |
| 7 | AMGN |
Amgen Inc
|
28,753 | $10,412,035 | |
| 8 | PFE |
Pfizer Inc
|
335,343 | $8,075,058 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,730,841 | 53,968 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $47,407,704 | 51,543 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $36,283,346 | 33,762 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $13,386,835 | 17,545 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $10,246,921 | 13,145 | Shares | Other | 2025-08-06 | |
| 2025-03-31 | $19,575,717 | 23,702 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $9,349,692 | 12,111 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $9,549,546 | 10,779 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,132,567 | 10,087 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $8,478,208 | 10,898 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,533,367 | 11,208 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,275,289 | 11,683 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $9,506,692 | 20,271 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $6,628,005 | 19,300 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $6,262,814 | 17,119 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $5,362,759 | 16,585 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $5,412,046 | 16,692 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,638,043 | 12,704 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $3,358,006 | 12,157 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,724,772 | 11,793 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,277,756 | 9,924 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,743,404 | 9,332 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,476,843 | 8,747 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,222,349 | 8,258 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $1,608,799 | 9,799 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,341,699 | 9,672 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||